‘I’m a psychologist who’s treated hundreds of patients with depression – this is ...
Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...
BioPharma Dive6 天
Neumora plummets on depression drug data
The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...
Stock in Biotech Neumora Plunges 80% as Depression Drug Fails
Shares of the biotech Neumora Therapeutics began the first trading day of 2025 with a loss of more than 80% after the company ...
Neumora Therapeutics Stock Tanks as Its Depression Drug Misses Goals
Key Takeaways Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged.The ...
Neumora Plunges After Major Depression Drug Fails in Study
Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...
Nigerian Tribune1 天
The facts, myths about depression
Depression is a common mental health condition and mood disorder that causes a persistent feeling of sadness and loss of ...
WFAE1 天
Tiny fish on ketamine may show how drug eases depression
In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...
Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials
Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...
Yahoo Finance6 天
Results are in for a new depression drug trial, and they're cratering this stock
After six weeks, both the treatment group and the placebo group experienced an average 12.5-point reduction on the Montgomery-Åsberg Depression Rating Scale (MADRS). The drug also fell short in i ...
Adam Collard admits pill addiction and depression battle in ‘hardest year’ of his life ...
ADAM Collard has opened up about his secret battle with depression in 2024 – calling it “the hardest year of my life”. The ...
Neumora Nosedives 80% At Pre-Market on Failed Depression Drug Trial
Neumora Therapeutics Inc. (NASDAQ: NMRA) nosedived by more than 80 percent during pre-market trading following disappointing ...
Reuters7 天
Neumora shares slump after depression drug fails in key trial
Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and ...